Conditioning regimen beneficial for kidney recipients

Conditioning regimen beneficial for kidney recipients
Following a conditioning regimen of lymphoid irradiation and antithymocyte globulin, the majority of HLA-matched kidney and hematopoietic cell transplant recipients can be withdrawn from immunosuppressive drugs, according to a small study published online March 8 in the American Journal of Transplantation.

(HealthDay) -- Following a conditioning regimen of lymphoid irradiation (TLI) and antithymocyte globulin (ATG), the majority of HLA-matched kidney and hematopoietic cell transplant recipients can be withdrawn from immunosuppressive drugs, according to a small study published online March 8 in the American Journal of Transplantation.

In a tolerance induction protocol, John D. Scandling, M.D., of the Stanford University School of Medicine in California, and colleagues studied 16 patients conditioned with TLI and ATG who were given kidney transplants and an injection of CD34+ hematopoietic progenitor cells and T cells from human leukocyte antigen-matched donors. Changes in chimerism, the balance of T-cell subsets, and responses to donor alloantigens were monitored.

The researchers found that 15 patients developed multilineage chimerism without graft-versus-host disease. In eight patients with chimerism for at least six months, antirejection medications were withdrawn for one to three years (mean, 28 months) without subsequent episodes of rejection. Drug withdrawal was occurring or had just occurred for four chimeric patients, and four patients experienced return of underlying disease or rejection episodes and consequently were not withdrawn. Compared with conventional naive CD4+ T cells, early high ratios of CD4+CD25+ and natural killer T cells were seen in blood cells from all patients. Patients who were off drugs demonstrated specific unresponsiveness to alloantigens from donors.

"TLI and ATG promoted the development of persistent chimerism and tolerance in a cohort of patients given kidney transplants and hematopoietic donor cell infusions," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Use of stem cells, conditioning induces immune tolerance

date Mar 08, 2012

(HealthDay) -- A novel approach using a bioengineered mobilized cellular product enriched with hematopoietic stem cells (HSCs) and tolerogenic graft facilitating cells (FCs) in combination with nonmyeloablative ...

Recommended for you

Level I trauma experience prepares surgeons for battle

date Jul 01, 2015

Soldiers injured during the conflicts in Iraq and Afghanistan have the highest survival rates in history, thanks to the availability of surgeons skilled in combat care. But combat-ready surgical skills are hard to sustain ...

Surgery may help adolescents with frequent migraines

date Jun 29, 2015

(HealthDay)—Migraine surgery may be an effective choice for adolescents who haven't gotten relief from standard treatment, a small study suggests. The findings were published in the June issue of Plastic an ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.